AMICUS THERAPEUTICS INC 4
4 · AMICUS THERAPEUTICS INC · Filed Oct 5, 2015
Insider Transaction Report
Form 4
Peist Kenneth
VP, Intellectual Property
Transactions
- Sale
Common stock
2015-10-01$13.14/sh−10,000$131,362→ 3,187 total - Exercise/Conversion
Stock Options (right to buy)
2015-10-01−10,000→ 25,000 totalExercise: $6.45From: 2016-02-01Exp: 2022-02-15→ Common Stock (10,000 underlying) - Exercise/Conversion
Common stock
2015-10-01$13.14/sh+10,000$131,362→ 13,187 total
Footnotes (3)
- [F1]The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
- [F2]This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.58 to $13.75. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.58 to $13.75. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.